Related Experiment Video
Updated: May 21, 2025

06:12
Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
1.3K
Partition-Less Digital Immunoassay Using Configurable Topographic Nanoarrays for Extracellular Vesicle Diagnosis of
Yunjie Wen1, Yutao Li1, Shibo Cheng1
1Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States.
ACS Nano
|March 21, 2025
Summary
A novel partition-free digital enzyme-linked immunosorbent assay (dELISA) called microfluidic Topographically Intensified, Partition-less dELISA (μTIP-dELISA) offers a simpler, more adaptable approach to bioanalysis. This digital bioassay significantly improves detection of cancer biomarkers in liquid biopsies.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Nanotechnology
Background:
- Digital bioassays enhance bioanalysis and diagnostics through improved analytical performance.
- Current methods often rely on partitioning single molecules, requiring complex fabrication and workflows.
- There is a need for simpler, more adaptable digital bioassay platforms.
Purpose of the Study:
- To develop a partition-free digital enzyme-linked immunosorbent assay (dELISA) using microfluidics.
- To enhance single-molecule signal amplification for improved bioassay sensitivity.
- To demonstrate the utility of the developed assay in cancer diagnostics.
Main Methods:
- Developed microfluidic Topographically Intensified, Partition-less dELISA (μTIP-dELISA) utilizing a micropost device for nanogap array formation.
- Employed single-molecule signal amplification to enhance surface-bound enzymatic reactions.
- Adapted μTIP-dELISA for extracellular vesicle (EV)-based liquid biopsy to detect Ewing sarcoma (EWS) biomarkers.
Main Results:
- Achieved >300-fold improvement over conventional ELISA for detecting four EWS protein biomarkers.
- Demonstrated highly sensitive and specific detection of EWS cases using a machine-learning-defined four-marker EV signature.
- Classified control, pediatric, and adult subjects with 97% accuracy, assessing age as a prognostic factor.
Conclusions:
- μTIP-dELISA offers simplicity, adaptability, and integrates microfluidic advantages for improved assay performance, throughput, scalability, and automation.
- The μTIP single-molecule signal amplification strategy can advance the development of digital bioassays.
- μTIP-dELISA serves as a valuable tool for clinical diagnostics in various malignancies.
Keywords:
Ewing sarcoma diagnosisdigital bioassaysextracellular vesiclepartition-less dELISAsingle-molecule signal amplification
